Juha Punnonen, M.D., Ph.D. Joins Hinge Bio as Chief Development Officer
/PRNewswire/ -- Hinge Bio, Inc., a privately-held biotechnology company, today announced that Juha Punnonen, M.D., Ph.D. has joined the company as Chief...
Stay updated with breaking news from External Collaborations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Hinge Bio, Inc., a privately-held biotechnology company, today announced that Juha Punnonen, M.D., Ph.D. has joined the company as Chief...
Toronto, ON (PRWEB) December 05, 2022 -- In immuno-oncology, biomarkers are widely used to guide clinical trial programs, help researchers better understand
03.01.2022 - CAMBRIDGE, Mass., Jan. 03, 2022 (GLOBE NEWSWIRE) - Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company advancing a robust pipeline of oncology and neuroscience product candidates that are designed to uniquely disrupt cellular ... Seite 1
Press release content from Globe Newswire. The AP news staff was not involved in its creation.